姓名：戴向晨

职称：主任医师

职务：天津人民医院经理

导师类型：博士研究生导师（学术型/专业型）

一、教育经历

2002.09-2005.07，天津医科大学，中西医结合临床专业，博士学位

1998.09-2001.07，天津医科大学，外科学（普外），硕士学位

1989.09-1994.07，天津医科大学，临床医学专业，本科，学士学位

二、工作经历

2026.01-至今，天津市人民医院，经理

2023.03-2026.01，天津医科大学总医院，副经理

2020.06-2023.10，天津医科大学总医院，普通外科科主任

2017.12-至今，天津医科大学,教授

2013.11-至今，天津医科大学总医院，主任医师

2006.09-2007.12，美国堪萨斯大学医学中心，博士后

三、研究方向

1. 主动脉疾病的力学-分子生物学发生及发展机制研究

2. 外周动脉疾病的生物信息学研究及临床对列研究

3. 血管疾病新器械的研发和转化研究

四、主持或参与科研项目（近五年）

1.国家自然科学基金专项项目，主动脉夹层近端修复术后远端假腔失稳重塑的机制与防治策略研究（联合申请A）编号：82241207，执行时间：2023.01-2025.12,200万元，负责人

2.国家自然科学基金面上项目，主动脉覆膜支架对升主动脉的力学损伤机制研究，编号：82070489，执行时间:2021.01-2024.12，55万元，负责人，结题

3.天津医科大学中西医结合学科提升计划，赤芍有效成分鞣花酸减轻主动脉内皮细胞损伤的分子机制研究，编号：2024XKZXY01，执行时间 2024.12-2027.12，20万元 ,负责人

4.天津市卫生健康委员会，天津市卫生健康科技项目，临床重点专科专项，腔内血栓促进腹主动脉瘤增长的机制及预警干预策略研究，编号 TJWJ2025ZK003，执行时间：2025.07-2028.06，50万元，负责人

5.天津市科技局，2025年天津市科学技术普及项目，面向中老年群体的血管健康专题科普宣传活动，编号：25KPXCRC00160，执行时间：2025.04-2027.03，3万元，负责人

6.天津市科技局，天津市科技计划重点项目，主动脉夹层假腔扩张的力学-血栓-炎症交互作用机制及干预策略研究，编号：25JCZDJC00790，执行时间：2025.04-2028.03，20万元，负责人

7.天津医科大学总医院临床重点项目，中国主动脉腔内隔绝术中桥接支架应用情况的前瞻性、多中心登记性临床实验研究，编号：22ZYYLCZD04，执行时间：2023-01-2025-12，80万元，负责人

8.天津市卫生信息学会科研项目，基于多模态临床数据的VTE动态风险预警大模型的构建与应用研究，编号：TJHIA-2026-005，执行时间：2025.7-2028.6，1万元，负责人

9.天津市卫生健康科技项目，青年项目，远端着陆区几何形态影响TEVAR术后残余夹层重塑的生物力学机制研究，编号：TJWJ2025QN016，执行时间：2025.07-2028.06，5万元，参与

10.国家科技重大专项，中华人民共和国科学技术部，B型主动脉夹层腔内诊疗策略的优化与质控，编号：2023ZD0504300，执行时间：2024.08 - 2028.07，4713.80 万元，参与

五、学术兼职

天津市医学会外科学分会第十届委员会副主任委员兼血管外科专业学组组长

中华医学会外科学分会第十九届委员会委员

杂志编辑

《中国临床案例成果数据库》审稿专家

《天津医药》第九届编辑委员会委员

《中华普通外科杂志》第六届编辑委员会编辑委员

《中华血管外科杂志（中英文）》第三届编辑委员会编辑委员

《frontiers in surgery》编委

六、主要科研成果（近五年）

SCI

1.Zhu J, Ma C, Dai X, Wang Z, Fan H, Feng Z, Luo Y, Zhang Y, Hu F. Outcomes of single physician-modified fenestrated stent grafts for endovascular repair of thoracic aortic lesions involving the distal aortic arch. Interact Cardiovasc Thorac Surg. 2021 Apr 19;32(4):560-565.

2.Chen Y, Pan H, Luo G, Li P, Dai X. Use of percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis: a systematic review andmeta-analysis. J Int Med Res. 2021 Jan;49(1):300060520983585.

3.Huang J, Dai X, Zhang X, Li J, Huang M, Liu C, Zhao Z, Xiao L, Liu L, Li N,Kong J, Han X. Retrievable inferior vena cava filter to prevent pulmonary embolism in patients with fractures and deep venous thrombosis of lower extremities: a single-center experience. J Int Med Res. 2021Apr;49(4):3000605211006591.

4.Chen J, Dai X, Zhu J, Hu F, Li P, Luo Y, Fan H, Feng Z, Zhang Y. One-stage supraclavicular hybrid procedure for type B aortic dissection involving threerare anatomical anomalies: a case report and literature review. J Int Med Res.2021 Jun;49(6):3000605211020241.

5.Bi J, Niu F, Li P, Dai X, Zhu J, Liu Z. Midterm outcomes of fenestrated TEVAR using physician-modified endovascular grafts for zone 2. Vascular. 2022 Jun;30(3):432-440.

6.Niu F, Liu Z, Liu P, Pan H, Bi J, Li P, Luo G, Chen Y, Zhang X, Dai X.Identification of novel genetic biomarkers and treatment targets for arteriosclerosis-related abdominal aortic aneurysm using bioinformatic tools.Math Biosci Eng. 2021 Nov 5;18(6):9761-9774.

7.Zhu J, Lv L, Dai X, Fan H, Luo Y, Feng Z, Zhang Y, Hu F. Primary Aortoduodenal Fistula in a Patient With Multiple Duodenal Diverticula. Ann Vasc Surg. 2022 Mar;80:394.e1-394.e4.

8.Liu L, Zhao J, Bi J, Dai X, Zhang X, He J, Fan H. Percutaneous Mechanical Atherothrombectomy Using the Rotarex Device in Acute Ischemic Disease of LowerLimbs: A China Retrospective Multicenter Study on 186 Patients. Ann Vasc Surg.2022 Sep;85:146-155.

9.Li P, Bi J, Niu F, Chen J, Dai X, Zhu J, Hu F. Mid-term Outcomes of Endovascular and Hybrid Procedures to Treat Complex Aortic Arch Pathologies. J Endovasc Ther. 2023 Oct;30(5):682-692.

10.Chen Y, Wang X, Bi J, Liu Z, Niu F, Zhang X, Dai X. Comparative clinical study of short-term outcomes between table fenestrated and chimney endovascular aneurysm repair for hostile neck aneurysms. Vascular. 2024 Apr;32(2):273-280

11.Liu Z, Bi J, Niu F, Liang H, Fan J, Li J, Wang D, Dai X. Construction of a canine model with acute type B aortic dissection using a self-made pressure-driven flow device. Exp Anim. 2023 May 17;72(2):253-261.

12.Liu Z, Chen Y, Qin Y, Bi J, Wang J, Niu F, Dai X. A nomogram risk assessment model to predict the possibility of type II endoleak-related re-interventionafter endovascular aneurysm repair (EVAR). Sci Rep. 2023 Jan 2;13(1):14.

13.Chen Y, Zhang L, Liu Z, Bi J, Niu F, Zhang X, Lu Q, Dai X. Fibrin Glue Sac Filling for Preventing Type II Endoleak, Short-Term Outcomes of a Prospective Randomized Controlled Trial. J Endovasc Ther. 2024 Oct;31(5):1005-1012

14.Xiao L, Gu S, Chen Y, Zhang X, Wang Y, Dai X. Midterm Results of Drug-Coated Balloon and Bare Metal Stent in the Treatment of TASCII C/D Femoropopliteal Artery Occlusive Disease: A Retrospective Multicenter Study. J Endovasc Ther. 2025 Oct;32(5):1417-1425

15.Liu Z, Feng G, Chen Y, Fan J, Liang Z, Bi J, Dai X. Hyperhomocysteinemia may aggravate abdominal aortic aneurysm formation by up-regulating RASSF2. Gene.2024 Mar 10;898:148036.

16.Chen Y, Liu Z, Wang S, D'Oria M, Zhang X, Bi J, Cui D, Dai X. Systematic Review and Meta-analysis of Short-term and Mid-term Outcomes After Use of t-Branch Off-the-shelf Multibranched Endograft for Elective and Urgent Treatment of Thoracoabdominal Aortic Aneurysms. J Endovasc Ther. 2025 Oct;32(5):1360-1373

17.E E, Wang D, Ma M, Liu Z, Dai X. Safety and Efficacy of Stent-Graft in the Treatment of Aortoiliac Artery Occlusive Disease: A Multicenter Study of Short-Term and Medium-Term Outcomes. Ann Vasc Surg. 2024 Jun;103:31-37

18.Ren J, Chen Y, E E, Ma M, Liu Z, Zhu J, Wang S, Bi J, Li P, Dai X. Midterm Outcomes of Multicenter Castor Single-Branch Stent Graft Use in the Treatment of Thoracic Aortic Diseases. J Endovasc Ther. 2025 Dec;32(6):2105-2114

19.Bi J, Dai X. Editorial: Critical issues and hot topics in endovascular repair of aortic dissection. Front Cardiovasc Med. 2024 Mar 21;11:1396852.

20.Chen Y, Ren J, Liu Z, Cui D, Wang S, Bi J, Dai X. Predictors for thoracic aortic growth in patients with type B aortic dissection after thoracic endovascular aortic repair. Vascular. 2025 Oct;33(5):1020-1027

21.Ji J, Bi J, Chen Y, Zhang X, Zhao B, Liang H, Fan J, Dai X. Mid-term outcomes of different treatments of internal iliac artery in endovascular aneurysm repair. Sci Prog. 2024 Jul-Sep;107(3):368504241274998

22.Bi J, Cui D, Liu Z, Wang J, Chen Y, Wang S, Guo J, Dai X. Stent Graft-Induced High Wall Stress Promoted Aortic Wall Failure and Aortic Wall Injurious Complications After TEVAR: A Study of Numerical Simulation and Bioinformatics Analysis Based on Pig Models. J Endovasc Ther. 2024 Sep 29:15266028241283324

23.Wang S, Chen Y, Liu Z, Ren J, Guo J, Wang J, Cui D, Bi J, Dai X. Long-Term Outcomes of PETTICOAT Technique-Assisted Thoracic Endovascular Aortic Repair for the Treatment of Acute and Subacute Complicated Type B Aortic Dissection. J Endovasc Ther. 2024 Oct 22:15266028241286808

24.Cui D, Li X, Liang Z, Chen J, Wang J, Guo J, Zhao B, Wang S, Li P, Bi J, Dai X. Mid-term outcomes of the fenestration, branched stent-graft, and hybrid techniques in the treatment of thoracic aortic pathologies involving the left subclavian artery. Vascular. 2025 Feb 24:17085381241312468

25.Liu L, Dai X, Zhang X, Huang J, Zhao Z, Liu C. An experimental study of a novel high-precision iliac vein pressure measuring device to evaluate iliac vein compression syndrome. Vascular. 2025 Mar 17:17085381251325652

26.Erdemutu E, Zhou C, Ma M, Hu L, Wu J, Dai X, Gao Z. Endovascular repair of abdominal aortic aneurysm-related type II endoleak: a multicenter study on the possibility of further intervention. Front Cardiovasc Med. 2025 Apr 17;12:1450942

27.Wang JX, Liu ZW, Zhang JT, Zhu HH, Jiao XY, Guo JY, Bi JX, Dai XC. Clinical Study of the Results of Sac Prefilling Performed to Prevent Type II Endoleaks After Endovascular Abdominal Aortic Aneurysm Repair. J Endovasc Ther. 2025 May 14:15266028251335771

28.Li J, Wang S, Wang S, Sun C, Dai X, Liu H. Biomechanical mechanisms behind the distal false lumen enlargement after TEVAR for type b aortic dissections: A computational one-way fluid-structure interaction study. J Biomech. 2025 Jul;188:112756

29.Li X, Chen Q, Li R, Shao B, Cui DS, Ren SH, Wang HD, Xu YN, Wang ZB, Wang XD, Ye K, Dai XC, Wang H. Insulin growth factor 2 contributes to adipose stem cell-derived exosome mediated angiogenesis against hind-limb ischemia injury. Cytokine. 2025 Sep;193:156984

30.Chen Y, Guo J, Wang S, Song Y, Dai X. Identifying Hemodynamic Predictors of Aortic Growth After Thoracic Endovascular Aortic Repair for Type B Aortic Dissection. J Endovasc Ther. 2025 Jul 12:15266028251352799

31.Liu Z, Xu C, Zhao B, Guo J, Song J, Bi J, Shen Y, Dai X. Quantitative evaluation of IVL: based on the tunica media gypsum calcification model and a prospective animal study. Front Cardiovasc Med. 2025 Jul 11;12:1620232

32.Liang H, Zhao B, Ren Y, Li P, Dai X. Application of Wharton's Jelly Mesenchymal Stem Cells in Critical Limb Ischemia. J Endovasc Ther. 2025 Aug 23:15266028251361770

33.Zhao B, Liang Z, Zhao X, Dai X. Cumulative estimated glucose disposal rate predicts frailty progression in Chinese adults with diabetes: a 9-year follow-up cohort study. Front Med (Lausanne). 2025 Dec 22;12:1617556

34.Zhao B, Liu Z, Liang H, Bi J, Dai X. Anatomy-driven strategies and mid-term outcomes of branched endovascular repair of the aortic arch: a single-center cohort study. J Cardiothorac Surg. 2026 Feb 9

35.Liang Z, Li X, Wang D, Zhao B, Bi J, Cui D, Wang J, Guo J, Wang S, Li Y, Dai X. Predicting the Severity of Infrapopliteal Artery Lesions in Patients With Peripheral Artery Disease Using Interpretable Machine Learning. J Endovasc Ther. 2026 Mar 5:15266028261425482

36.Cui D, Li X, Chen Y, Zhang X, Huang J, Bi J, Dai X. Risk Factor Analysis of Post-TEVAR Distal Aortic Expansion: A Systematic Review and Meta-Analysis. J Endovasc Ther. 2026 Mar 15:15266028261428261

37.Li Y, Aierken Y, Liang Z, Wang Y, Sun Y, Liu Z, Guo J, Wang J, Bi J, Dai X. Visualization analysis of research hotspots and trends in Type B Aortic Dissection based on bibliometrics. J Cardiothorac Surg. 2026 May 3

38.Cui D, Li X, Xu C, Pan H, Fang L, Bi J, Dai X. Male Sex and Distal Aortic Expansion After TEVAR: A Single-Center Analysis with Bayesian Evidence Synthesis. Ann Vasc Surg. 2026 May 6:S0890-5096(26)00270-0

北大核心中文期刊

1.秘家学,戴向晨,罗宇东,朱杰昌,范海伦,冯舟,张益伟,胡凡果.预开窗与外分支主动脉腔内修复术治疗主动脉病变的近期效果分析[J].中华医学杂志,2021,101(06):405-409.

2.潘红瑞,戴向晨,曲超,陈永辉,牛放,刘宗玮,罗光泽,李文健.累及主动脉弓部夹层动物模型构建方法的对比研究[J].中华医学杂志,2021,101(9):647-653.

3.曲超,戴向晨,秘家学,牛放.胸腹主动脉瘤39例诊治经验[J].中华普通外科杂志,2021,36(6):451-456.

4.李亮,刘向东,李云松,张彦荣,戴向晨.腔内隔绝术治疗外周血管损伤的近中期疗效分析[J].中华普通外科杂志,2021,36(7):547-548.

5.朱杰昌,戴向晨,罗宇东,冯舟,张益伟.症状性腹主动脉瘤压迫十二指肠的临床诊疗分析[J].中华普通外科杂志,2022,37(3):214-215.

6.刘宗玮，戴向晨. 胸主动脉腔内修复术术后支架近端新发破口引起逆向撕裂Stanford A型主动脉夹层的研究进展. 中华医学杂志，2022，102(38):3063-3067

7.马超,张杰,肖明,康楠,陈永辉,戴向晨.超声造影检测肾下型腹主动脉瘤腔内修复术后内漏的价值[J].中华医学杂志,2023,103(27):2106-2111

8.刘宗玮,戴向晨.下肢动脉重度钙化闭塞病变管腔处理措施的研究进展[J].中华普通外科杂志,2023,38(11):873-877

9.高鹏,郭宝磊,张明,戴向晨,刘浩飞.考虑三维残余变形的主动脉生理稳态建模[J].医用生物力学,2024,39(03):510-517

10.李鹏,梁浩,赵彬,戴向晨. 可控预开窗技术处理主动脉弓部病变的中期疗效[J]. 中华普通外科杂志,2024,39(9):673-680

11.张跃凡,郭宝磊,孙翠茹,戴向晨,刘浩飞.一种基于流固耦合并考虑主动脉残余应力与超弹性的血压预测方法[J].医用生物力学,2025,40(01):49-57

12.朱杰昌,王峥,胡凡果,罗宇东,戴向晨.原发和继发性腹主动脉-十二指肠瘘的诊疗分析[J].中华普通外科杂志,2025,40(11):891-892

13.孙元昊,罗光泽,秘家学,李鹏,朱杰昌,范海伦,戴向晨.腹主动脉瘤EVAR术后进展性Ⅱ型内漏的相关危险因素及风险预测模型研究[J].中国普通外科杂志,2025,34(12):2596-2604

发明专利

一种分段式主动脉分支型覆膜支架  专利号：ZL 2018 1 0133271.2   授权公告日：2024年02月23日  第一发明人

著作

《普通外科专培实战病例解析》科学技术文献出版社主编  出版时间2023年9月

《主动脉疑难病例腔内治疗新技术实战解析》  科学技术文献出版社主编  出版时间2024年12月

《血管外科与肿瘤诊疗学》中国科学技术出版社主译出版时间 2025年5月

近 5 年发表论文80 余篇，其中SCI 收录论文52 篇（第一或通讯38 篇），参与编译专著3 部，参与编写专家共识6篇。

七、荣誉与奖励

2025年，天津市科学技术进步二等奖，力学赋能的主动脉夹层精准微创诊疗体系的建立与应用，第一完成人

2020年，天津市科学技术进步二等奖，体外开窗系列技术治疗主动脉关键区域病变的技术创新及临床应用，第一完成人

2020年获首届天津名医称号